vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and SOUTHSIDE BANCSHARES INC (SBSI). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $62.8M, roughly 1.3× SOUTHSIDE BANCSHARES INC). SOUTHSIDE BANCSHARES INC runs the higher net margin — 33.4% vs 6.8%, a 26.6% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -4.8%). SOUTHSIDE BANCSHARES INC produced more free cash flow last quarter ($73.5M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Southside Bancshares Inc. is a U.S.-based bank holding company primarily operating in Texas. It offers a full range of personal and commercial banking services including deposit accounts, mortgage, consumer and commercial loans, and wealth management solutions, serving retail customers, small and medium-sized enterprises and local community groups.
BLLN vs SBSI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $62.8M |
| Net Profit | $5.7M | $21.0M |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | 39.4% |
| Net Margin | 6.8% | 33.4% |
| Revenue YoY | 117.4% | -4.8% |
| Net Profit YoY | 138.3% | -3.7% |
| EPS (diluted) | $0.10 | $0.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $62.8M | ||
| Q3 25 | $83.5M | $43.7M | ||
| Q2 25 | — | $66.4M | ||
| Q1 25 | — | $64.1M | ||
| Q4 24 | $45.1M | $66.0M | ||
| Q3 24 | $38.4M | $63.6M | ||
| Q2 24 | — | $65.2M | ||
| Q1 24 | — | $63.1M |
| Q4 25 | — | $21.0M | ||
| Q3 25 | $5.7M | $4.9M | ||
| Q2 25 | — | $21.8M | ||
| Q1 25 | — | $21.5M | ||
| Q4 24 | $-11.5M | $21.8M | ||
| Q3 24 | $-14.9M | $20.5M | ||
| Q2 24 | — | $24.7M | ||
| Q1 24 | — | $21.5M |
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 39.4% | ||
| Q3 25 | 11.5% | 11.7% | ||
| Q2 25 | — | 40.0% | ||
| Q1 25 | — | 40.9% | ||
| Q4 24 | 17.0% | 40.1% | ||
| Q3 24 | -32.9% | 39.2% | ||
| Q2 24 | — | 45.9% | ||
| Q1 24 | — | 41.4% |
| Q4 25 | — | 33.4% | ||
| Q3 25 | 6.8% | 11.2% | ||
| Q2 25 | — | 32.8% | ||
| Q1 25 | — | 33.6% | ||
| Q4 24 | -25.5% | 33.0% | ||
| Q3 24 | -38.8% | 32.3% | ||
| Q2 24 | — | 37.9% | ||
| Q1 24 | — | 34.1% |
| Q4 25 | — | $0.70 | ||
| Q3 25 | $0.10 | $0.16 | ||
| Q2 25 | — | $0.72 | ||
| Q1 25 | — | $0.71 | ||
| Q4 24 | $-1.13 | $0.71 | ||
| Q3 24 | $-1.47 | $0.68 | ||
| Q2 24 | — | $0.81 | ||
| Q1 24 | — | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $389.8M |
| Total DebtLower is stronger | $55.0M | $300.0M |
| Stockholders' EquityBook value | $-239.5M | $847.6M |
| Total Assets | $327.5M | $8.5B |
| Debt / EquityLower = less leverage | — | 0.35× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $389.8M | ||
| Q3 25 | $195.2M | $466.9M | ||
| Q2 25 | — | $390.1M | ||
| Q1 25 | — | $431.0M | ||
| Q4 24 | $191.5M | $426.2M | ||
| Q3 24 | — | $486.3M | ||
| Q2 24 | — | $452.0M | ||
| Q1 24 | — | $469.4M |
| Q4 25 | — | $300.0M | ||
| Q3 25 | $55.0M | $299.9M | ||
| Q2 25 | — | $152.4M | ||
| Q1 25 | — | $152.4M | ||
| Q4 24 | $51.5M | $152.3M | ||
| Q3 24 | — | $152.3M | ||
| Q2 24 | — | $152.2M | ||
| Q1 24 | — | $154.2M |
| Q4 25 | — | $847.6M | ||
| Q3 25 | $-239.5M | $834.9M | ||
| Q2 25 | — | $807.2M | ||
| Q1 25 | — | $816.6M | ||
| Q4 24 | $-251.7M | $811.9M | ||
| Q3 24 | $-242.9M | $805.3M | ||
| Q2 24 | — | $801.0M | ||
| Q1 24 | — | $787.9M |
| Q4 25 | — | $8.5B | ||
| Q3 25 | $327.5M | $8.4B | ||
| Q2 25 | — | $8.3B | ||
| Q1 25 | — | $8.3B | ||
| Q4 24 | $302.1M | $8.5B | ||
| Q3 24 | — | $8.4B | ||
| Q2 24 | — | $8.4B | ||
| Q1 24 | — | $8.4B |
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.19× | ||
| Q2 24 | — | 0.19× | ||
| Q1 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $93.8M |
| Free Cash FlowOCF − Capex | $6.5M | $73.5M |
| FCF MarginFCF / Revenue | 7.7% | 117.0% |
| Capex IntensityCapex / Revenue | 8.8% | 32.4% |
| Cash ConversionOCF / Net Profit | 2.42× | 4.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $130.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $93.8M | ||
| Q3 25 | $13.8M | $40.2M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $23.9M | ||
| Q4 24 | — | $101.8M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $58.3M |
| Q4 25 | — | $73.5M | ||
| Q3 25 | $6.5M | $37.4M | ||
| Q2 25 | — | $-2.0M | ||
| Q1 25 | — | $21.5M | ||
| Q4 24 | — | $90.7M | ||
| Q3 24 | — | $-14.2M | ||
| Q2 24 | — | $15.4M | ||
| Q1 24 | — | $55.7M |
| Q4 25 | — | 117.0% | ||
| Q3 25 | 7.7% | 85.5% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | — | 33.6% | ||
| Q4 24 | — | 137.4% | ||
| Q3 24 | — | -22.3% | ||
| Q2 24 | — | 23.6% | ||
| Q1 24 | — | 88.4% |
| Q4 25 | — | 32.4% | ||
| Q3 25 | 8.8% | 6.5% | ||
| Q2 25 | — | 12.0% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | 4.1% |
| Q4 25 | — | 4.47× | ||
| Q3 25 | 2.42× | 8.18× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 4.67× | ||
| Q3 24 | — | -0.57× | ||
| Q2 24 | — | 0.67× | ||
| Q1 24 | — | 2.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
SBSI
Segment breakdown not available.
